Generative artificial intelligence, which takes machine learning and data analytics to the next level, has a huge potential impact on the healthcare industry at all levels – and this is generating a lot of investment and will lead to M&A activity in the sector, reports Mergers & Acquisitions.
“Administrative applications are getting a lot more attention now,” says VSS Principal Eric Kim. “The clinical side is longer-term.” Even for the near-term administrative side, though, AI strictly speaking is still in its infancy and it’s premature to speak of M&A activity, adds Kim, a former Optum managing director. “There is a lot of funding activity,” he says, to develop AI so that it can start supporting healthcare activities and increase value for PE investors. Read more.
